Elyxium Wealth’s Inspire Medical Systems INSP Stock Holding History

Elyxium Wealth’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$92	–	687
2025 Q4	$92	Buy	+1	New	+$96	﹤0.01%	1335

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Elyxium Wealth's INSP Position: Q1 2026 in Review

Elyxium Wealth sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 1 share — an estimated $92 sold.

Elyxium Wealth first reported a position in INSP in Q4 2025 and held it in 1 quarter. The position peaked at $92 in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

Elyxium Wealth reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
Elyxium Wealth sold 1 Inspire Medical Systems share in Q1 2026, an estimated $92.
Elyxium Wealth first reported a position in Inspire Medical Systems in Q4 2025 and held it in 1 quarter.
Elyxium Wealth's Inspire Medical Systems position peaked at $92 in Q4 2025.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.